Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
B. Riley Reaffirms "Buy" Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
07:18am, Wednesday, 01'st Apr 2020
Arrowhead Pharmaceuticals (NASDAQ:ARWR)‘s stock had its “buy” rating reissued by B. Riley in a note issued to investors on Tuesday, TipRanks reports. They presently have a $57.00 price target on
Arrowhead Pharmaceuticals (ARWR) Receives a Buy from B.Riley FBR
04:06pm, Tuesday, 31'st Mar 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report) today and set a
AQR Capital Management LLC Sells 39,881 Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
09:22am, Monday, 30'th Mar 2020
AQR Capital Management LLC trimmed its position in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 24.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional inves
1832 Asset Management L.P. Lowers Stake in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
08:22am, Monday, 30'th Mar 2020
1832 Asset Management L.P. cut its stake in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 11.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Short Interest Down 5.2% in March
05:00am, Monday, 30'th Mar 2020
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) saw a significant decrease in short interest in March. As of March 13th, there was short interest totalling 8,270,900 shares, a decrease of 5.2% from the Fe
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Shares Acquired by Brinker Capital Inc.
10:28am, Sunday, 29'th Mar 2020
Brinker Capital Inc. lifted its stake in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The i
Bank of New York Mellon Corp Decreases Position in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
11:16am, Saturday, 28'th Mar 2020
Bank of New York Mellon Corp lessened its holdings in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 3.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Com
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Shares Sold by Bamco Inc. NY
09:32am, Saturday, 28'th Mar 2020
Bamco Inc. NY decreased its stake in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 52.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) Given Consensus Rating of "Hold" by Analysts
09:58am, Thursday, 26'th Mar 2020
Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) have been assigned an average rating of “Hold” from the thirteen brokerages that are covering the stock, MarketBeat.com reports. One analyst h
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics
07:00pm, Wednesday, 25'th Mar 2020
After years of research, technology for silencing a gene---stopping it from producing a disease-causing protein---has reached patients. AstraZeneca is now
Selloff creating bargains in healthcare - Baird
05:54pm, Wednesday, 25'th Mar 2020
Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI
Advisor Group Inc. Purchases 3,508 Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
08:14am, Wednesday, 25'th Mar 2020
Advisor Group Inc. increased its position in shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 85.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC.
Stocks Showing Rising Market Leadership: Arrowhead Pharma Earns 82 RS Rating
12:00am, Wednesday, 25'th Mar 2020Blair likes Incyte in premarket analyst action
11:53am, Tuesday, 24'th Mar 2020
Compugen (NASDAQ:CGEN) initiated with Buy rating and $16 (156% upside) price target at SunTrust. Shares up 9% premarket.Incyte (NASDAQ:INCY) resumed with Outperform rating at William Blair. Shares u
